1 matches for your search in the start-up spotlight
rss
matching the following criteria
Sort by:
CatalYm GmbH
CatalYm is a biopharmaceutical company developing novel cancer immunotherapies targeting Growth-and-Differentiation Factor 15 (GDF-15). Apart from its established role in cachexia, GDF-15 has been associated with immunosuppression in tissues and tumors and a rapidly growing body of literature ...
